155 filings
Page 5 of 8
8-K
akdpazrepyablsxz i5
5 Aug 20
Kezar Life Sciences Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update
4:05pm
8-K
s9fsw0l 4r
26 Jun 20
Submission of Matters to a Vote of Security Holders
4:40pm
8-K
c3bk ftz1ujzd466c
10 Jun 20
Kezar Announces Pricing of a Public Offering of $46.7 million of Common Stock andPre-Funded Warrants
9:29am
424B5
70kltzg
10 Jun 20
Prospectus supplement for primary offering
9:27am
424B5
ln3lpyc6o piavw5m
8 Jun 20
Prospectus supplement for primary offering
4:07pm
8-K
dckh4y1kiv 9sxcdm1
8 Jun 20
Special Note Regarding Forward-looking Statements
6:21am
424B5
33h x8hxfk4ojzrbunrf
8 Jun 20
Prospectus supplement for primary offering
6:17am
8-K
7vd d3d03yhpcyxrr9y
3 Jun 20
Kezar Provides Data Update from MISSION Study of KZR-616
5:17pm
8-K
h4z35th0
7 May 20
Kezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
4:08pm
DEFA14A
gyd97pbf7x g6rsgvcc6
29 Apr 20
Additional proxy soliciting materials
4:58pm
8-K
w956ffmzlz650f1
9 Apr 20
Kezar Provides Statement Regarding COVID-19 Pandemic
8:31am
S-8
ypd2kt zh5pi4dg5y6i
12 Mar 20
Registration of securities for employees
5:07pm
8-K
y0fxl9rwpv6i6xhk
12 Mar 20
Kezar Life Sciences Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update
4:05pm
8-K
45hjo6x
3 Feb 20
Kezar Announces Pricing of $49.4 Million Public Offering of Common Stock andPre-Funded Warrants
5:30pm
424B5
dvqzxr4
3 Feb 20
Prospectus supplement for primary offering
5:29pm